Statistics on Biotechnology Use Results by sector of operation Sector Companies. Results in biotechnology for main variables and branches of activity Unidades: specified in variables Total Companies Services Industry and Construction Agriculture No. of companies carrying out R&D in Biotechnology 1.079 679 320 81 %Companies according to biotechnology used: Genetic code 35 42 17 46 %Companies according to biotechnology used: Functional units 44 48 41 27 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 26 31 16 26 %Companies according to biotechnology used: Bioprocesses 49 40 75 29 %Companies according to biotechnology used: Sub-cellular organisms 8 11 5 2 %Companies according to biotechnology used: Bio-computing 23 32 8 5 %Companies according to biotechnology used: Nanobiotechnology 15 20 7 2 %Companies according to biotechnology used: Other 12 13 9 22 Companies in which biotechnology activities are: Main and/or exclusive 519 436 72 11 Companies in which biotechnology activities are: A secondary line of business 179 107 57 15 Companies in which biotechnology activities are: A tool necessary for production 381 136 190 55 %Company by field(s) of ultimate application of biotechnology use: Human Health 48 62 28 3 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 21 23 13 36 %Company by field(s) of ultimate application of biotechnology use: Food products 33 25 51 33 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 22 19 18 58 %Company by field(s) of ultimate application of biotechnology use: Environment 17 18 19 11 %Company by field(s) of ultimate application of biotechnology use: Industry 15 17 13 3 Personnel in R&D in biotechnology (no. of persons) 9.795 6.459 2.590 745 Personnel in R&D in biotechnology (no. of persons): Researchers 5.573 4.149 1.190 234 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 4.222 2.310 1.401 511 Personnel in R&D in biotechnology (no. of persons): women 5.298 3.701 1.308 290 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 2.925 2.230 611 84 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 2.373 1.471 696 206 Personnel in R&D in biotechnology (FTE) 6.828,6 4.786,1 1.592,7 449,8 Personnel in R&D in biotechnology (FTE): Researchers 4.106,5 3.140,9 811,9 153,7 Personnel in R&D in biotechnology (FTE): Technicians and assistants 2.722,1 1.645,2 780,8 296,2 Personnel in R&D in biotechnology (FTE): women 3.811,7 2.728 883,7 200 Personnel in R&D in biotechnology (FTE): (women) Researchers 2.190,7 1.684,7 447,7 58,4 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.621 1.043,4 436 141,6 Internal expenditure on R&D (thousands of euros) 533.826 357.195 150.471 26.160 1) By nature of the expense: Current expenses 492.955 329.995 141.459 21.501 1.1) Remuneration to researchers 203.439 144.769 51.775 6.895 1.2) Remuneration to technicians and assistants 96.850 50.585 38.481 7.784 1.3) Other current expenses 192.666 134.641 51.202 6.822 2) By nature of the expense: Capital expenses 40.870 27.199 9.012 4.659 2.1) Land and buildings 7.521 3.248 1.126 3.147 2.2) Equipment and instruments 32.078 22.730 7.856 1.492 2.3) Acquisition of specific R&D software 1.270 1.221 29 20 1) By origin of the funds: National funds 432.869 285.287 122.831 24.752 1.1) Own funds 319.046 179.647 116.254 23.144 1.2) From companies 39.253 38.264 989 0 1.3) Public Administration funds 70.063 62.869 5.587 1.607 1.4) From Universities 156 156 0 0 1.5) From non profit private institutions 4.351 4.351 0 0 1) By origin of the funds: Foreign funds 100.956 71.908 27.640 1.409 2.1) From EU programmes 20.070 18.776 886 408 2.2) Other foreign funds 80.886 53.131 26.754 1.001 Purchase of R&D services in biotechnology (thousands of euros) 138.625 52.251 83.896 2.478 Purchase of R&D services in biotechnology (thousands of euros): In Spain 101.114 41.915 57.089 2.109 Purchase of R&D services in biotechnology (thousands of euros): Abroad 37.512 10.336 26.807 369 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 46 56 30 31 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 13 11 16 14 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 12 13 11 12 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 14 16 13 7 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 19 21 17 8 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 19 24 13 6 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 18 20 13 17 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 37 39 35 22 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 49 52 44 46 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 19 21 17 12 % Companies that have requested biotechnology patents in Biotechnology 15 19 10 3 Number of patents requested 466 338 101 27 % Companies with income of an international origin related to biotechnological activities 24,9 27 23,8 11,9 % Turnover representing income of an international origin related to biotechnological activities 0,9 4,5 0,8 1,1 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 71,3 51,6 76,3 24,5 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 28,7 48,4 23,7 75,5 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 92,2 55,4 99,5 92,4 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 2,4 14,1 0 4,1 % Income of an international origin related with activities according to the classification: Operating source abroad 1,3 7 0,1 . % Income of an international origin related with activities according to the classification: Other 4,2 23,5 0,4 3,5 Notas: . '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute